Healthcare Industry Sevoflurane, Isoflurane and Desflurane Market

Your Catalyst To a Lucrative Business
Sevoflurane, Isoflurane and Desflurane Market Share, Size,
Analysis, Growth, Trends and Forecasts to 2022 | Hexa Research
" The Sevoflurane, Isoflurane and Desflurane Market
is expected to reach USD 1.5 billion by 2022 in
comparison to USD 1.2 billion in 2014."
The Sevoflurane, Isoflurane and Desflurane Market is expected to reach USD 1.5 billion by 2022 in
comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by
anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very
strong and cost less, with minimum damage to the ozone layer.
Market Drivers
One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market
includes cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer, orthopedic,
spinal and gastro-intestinal cases have also furthered the market. Cataract surgery is a major contributor to
the global market and will need a higher production of these chemicals.
Growing accidents and emergency cases also add income to the inhalation anesthesia market. Universal
insurance coverage as well as constant improvements in medical infrastructure also ensure the development
of the sevoflurane, isoflurane and desflurane market. These agents are administered to patients prior
surgery, making the induction of general anesthesia much simpler.
A major factor hindering the market is the quantity of CO 2 released in the environment, leading to global
warming. Actually, only about 5 percent of the gases are consumed by patients. The rest are released int o the
atmosphere and make it unhealthy. The most practical solution for this problem is the anesthetic recycling of
products used during the administration of general anesthesia.
Browse Details of Report@ https://www.hexaresearch.com/research-report/sevoflurane-isoflurane-
desflurane-industry
Follow Us: